Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease
Philip C. Robinson(The University of Queensland), Mark Nidorf(Genesis HealthCare), Jan H. Cornel(Brigham and Women's Hospital), Binita Shah(New York University), David Liew(The University of Melbourne), Massimo Imazio(University of Udine), Eleni Karatza(National and Kapodistrian University of Athens), Robert Terkeltaub(University of California San Diego), Michael H. Pillinger(VA NY Harbor Healthcare System), Peter L. Thompson(Sir Charles Gairdner Hospital), Vangelis Karalis(National and Kapodistrian University of Athens)
Cited by 122
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
Rosuvastatin in Older Patients with Systolic Heart Failure
|New England Journal of Medicine|2007|1.5k